Seeking Alpha
 

Aetna, Inc. (AET)

- NYSE
  • Apr. 17, 2013, 12:33 PM
    The big surge in health care stocks earlier this month just prior to the government's decision on Medicare Advantage rates may have been due to an email to sent by a former top congressional aide who now happens to be an outside lobbyist for Humana (HUM -1.9%). The email, which is now subject to an SEC probe, was sent to a Washington investment-research firm and circulated to clients just minutes before the close of trading, saying that "credible sources" had told them a decision had been made to restore the payments.
    | 4 Comments
  • Apr. 1, 2013, 6:12 PM
    The Centers for Medicare and Medicaid Services, after originally calling for reducing Medicare Advantage payments in February, seem to have reversed course, now projecting that combined growth in Medicare Advantage rates and fee-for-service rates will be 3.3%. Though it's unclear precisely what that may mean for health insurers, the markets are taking it as a positive: HUM +9%, AET +2.3%, WCG +4.1%, UNH +4% AH.
    | 3 Comments
  • Apr. 1, 2013, 4:08 PM
    Health insurers surge into the close as the final notice on Medicare Advantage reimbursement is due today: Humana (HUM +8.6%), UnitedHealth (UNH +3.1%), Wellcare Healthplans (WCG +3.9%), Coventry Health (CVH +1%) Centene (CNC +1%) and Aetna (AET +2.5%).
    | Comment!
  • Feb. 19, 2013, 9:39 AM
    It's not just Humana (-9.6%) suffering from prospective declines in reimbursement rates for Medicare Advantage plans in 2014, with UnitedHealth (UNH) -5.2%, Cigna (CI) -5.5%, Aetna (AET) -3.5% and Universal America (UAM) -8.95%.
    | 7 Comments
  • Feb. 6, 2013, 8:05 AM
    More on Coventry Health Care (CVH) Q4: net profit +39% to $119.3M. Operating expenses +9.6% despite the medical-loss ratio falling to 82.7% from 84.4% in Q3, and membership declining to 5.36M from 5.37M. Aetna (AET) investors are likely to take an interest, given that the company is buying Coventry for $5.7B.
    | Comment!
  • Feb. 6, 2013, 6:33 AM
    Coventry Health Care (CVH): Q4 EPS of $0.88 beats by $0.2. Revenue of $3.4B (+10% Y/Y) misses by $0.11B. (PR)
    | Comment!
  • Feb. 6, 2013, 12:05 AM
    Notable earnings before Wednesday’s open: ABMD, AINV, CMI, CMP, CVH, CVS, ELN, GAS, ICE, IVR, MPEL, MRO, MT, NUS, PLD, RL, TWX, USG, VICL, VMED
    | Comment!
  • Feb. 5, 2013, 5:30 PM
    Notable earnings before Wednesday’s open: ABMD, AINV, CMI, CMP, CVH, CVS, ELN, GAS, ICE, IVR, MPEL, MRO, MT, NUS, PLD, RL, TWX, USG, VICL, VMED
    | Comment!
  • Jan. 31, 2013, 8:07 AM
    More on Aetna (AET) Q4: net profit -49% to $190.1M, partly because of $120M in litigation expenses and other one-time items. Medical benefit ratio rises to 84.1% from 80.7%, membership +64K to 18.2M. Affirms guidance for FY EPS of at least $5.40. Names Shawn Guertin as CFO to replace Joseph Zubretsky, who will head a new unit called National Businesses. Guertin was CFO at Coventry Healthcare, which Aetna is buying.
    | Comment!
  • Jan. 31, 2013, 6:01 AM
    Aetna (AET): Q4 EPS of $0.94 misses by $0.02. Revenue of $8.96B (+5% Y/Y) misses by $0.01B. (PR)
    | Comment!
  • Jan. 31, 2013, 12:05 AM
    Notable earnings before Thursday’s open: AET, ALKS, AN, APU, AZN, BEAV, BLL, BMS, BX, CAM, CL, CNH, CNX, COCO, CRR, D, DB, DNKN, DOW, EPD, ERIC, EXXI, HAR, HGG, HP, HSH, HSY, IVZ, LQDT, MA, MJN, MO, MTG, MWW, NDAQ, NVO, OXY, PBI, PCAR, PENN, PHM, POT, R, RCL, RGLD, SHW, TE, TEN, TMO, TWC, UA, UGI, UPS, VIAB, WHR, XEL, ZMH
    | Comment!
  • Jan. 30, 2013, 5:30 PM
    Notable earnings before Thursday’s open: AET, ALKS, AN, APU, AZN, BEAV, BLL, BMS, BX, CAM, CL, CNH, CNX, COCO, CRR, D, DB, DNKN, DOW, EPD, ERIC, EXXI, HAR, HGG, HP, HSH, HSY, IVZ, LQDT, MA, MJN, MO, MTG, MWW, NDAQ, NVO, OXY, PBI, PCAR, PENN, PHM, POT, R, RCL, RGLD, SHW, TE, TEN, TMO, TWC, UA, UGI, UPS, VIAB, WHR, XEL, ZMH
    | Comment!
  • Jan. 22, 2013, 10:08 AM
    Aetna (AET +0.5%) agrees to sell its Medicaid business Missouri Care to WellCare Health Plans (WCG -0.3%) as part of Aetna's $5.6B acquisition of Coventry Health Care (CVH +0.1%). A combination of Aetna's and Coventry's Medicaid plans in Missouri would exceed permissible membership thresholds under the state's contracts. Financial terms weren't disclosed. (PR)
    | Comment!
  • Dec. 30, 2012, 11:35 AM
    At $28K a vial, Questcor's (QCOR) Acthar has propelled shares to huge gains. QCOR bought the drug for $100K in 2001, planning to produce it only to treat infantile spasms. But thanks to aggressive marketing, it's now being prescribed for MS, arthritis, and kidney disease. Aetna's (AET) decision to limit off-label treatments has hit shares, but it's not clear any viable alternatives are on the horizon. (NYT)
    | 32 Comments
  • Dec. 12, 2012, 10:06 AM
    Aetna (AET), which is holding its investor day, joins United Health and Cigna in providing 2013 guidance that's below consensus. Aetna forecasts EPS of at least $5.40 vs consensus of $5.52 and revenue growth of 9% to $38.6B vs $38.91B. Predicts that commercial-medical costs will rise 6.5%, the same as this year. BMO analyst Dave Shove says the outlook reflects "management’s cautious stance on guiding high." Shares +4.2%.
    | Comment!
  • Dec. 7, 2012, 9:34 AM
    Aetna (AET +2.4%) settles for $120M (subject to judge's approval) a class action suit relating to payments of claims to Aetna members who were served by non-contracted health-care providers. In other news, the stock is upgraded to Overweight with $52 price target by JPMorgan.
    | Comment!
Visit Seeking Alpha's
AET vs. ETF Alternatives
Company Description
Aetna Inc. is a health care benefit company, which offers traditional and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans.
Sector: Healthcare
Country: United States